Olanzapine Treatment for Refractory Nausea and Vomiting After Transarterial Embolization for Cerebral Arteriovenous Malformation

Am J Ther. 2020 Nov/Dec;27(6):e660-e663. doi: 10.1097/MJT.0000000000001030.
No abstract available

MeSH terms

  • Antiemetics* / therapeutic use
  • Embolization, Therapeutic*
  • Humans
  • Intracranial Arteriovenous Malformations* / complications
  • Intracranial Arteriovenous Malformations* / drug therapy
  • Nausea / chemically induced
  • Nausea / drug therapy
  • Olanzapine / therapeutic use
  • Vomiting / chemically induced
  • Vomiting / drug therapy

Substances

  • Antiemetics
  • Olanzapine